Developing Strategies for Effective and Efficient Immunization Against COVID-19
Many challenges plague immunization strategies once a COVID-19 vaccine is available. This includes the inability of current manufacturing capacities to meet the global demand, distributional challenges in the supply chain, tiered pricing of vaccines across countries, and unequal benefits from vaccination in the population. How can health economists help policymakers rise to the challenge?
The webinar will focus on three main aspects with regards to defining capacities in economics that the countries need to invest in for the most effective and efficient immunization strategy.
- Considerations in determining if all or select populations are to be immunized
- Financing of the vaccines by countries and donors
- Building and maintaining vaccine distribution channels
The panel of speakers will present their perspectives on these issues, and provide recommendations on which is the most cost-effective and equitable way to finance and distribute vaccinations.
- Anuradha Gupta
Anuradha Gupta is Deputy Chief Executive Officer of Gavi, the Vaccine Alliance. She has led efforts to put equity and gender at the centre of Gavi’s programmatic planning and to tailor support to countries within Gavi’s strategy. She has also driven efforts to create a new model of country-level Alliance support, through the establishment of the partners’ engagement framework (PEF). In 2015, she was named one of “300 Women Leaders in Global Health” by the Global Health Centre of the Graduate Institute of International and Development Studies.
- Professor Prashant Yadav
Prashant Yadav, PhD is an Affiliate Professor of Technology and Operations Management at INSEAD. Yadav’s work focuses on improving healthcare supply chains and designing better supply chains for products with social benefits. Before coming to INSEAD Prashant was Strategy Leader-Supply Chain at the Bill & Melinda Gates Foundation. He serves on the boards of many global organizations and social enterprises. He has been invited for expert testimony on issues related to medicine supply chains in the US Congress and legislative bodies in other countries.
- Dr. Anthony Kinghorn
Dr Anthony Kinghorn is a medical doctor, health economist and public health practitioner. He is a senior advisor to the PRICELESS initiative at University of the Witwatersrand in Johannesburg which is generating health economic information and processes to support decision making and effective prioritization by policy makers in South and Southern Africa. He has led a range of operational and health economics research, as well as other management and planning consultancies since the 1990s in many Southern, Eastern and West African countries. These have included costing and economic evaluations of specific services and interventions, and fiscal and other projection work.
- Dr. Awad Mataria
Dr. Awad Mataria is a Health Economist working at the World Health Organization, Regional Office for the Eastern Mediterranean. His areas of expertise cover research in economic evaluation of health care interventions (cost-effectiveness analysis, cost-utility analysis and cost-benefit analyses); using economics in health care priority setting, financing and organization of health care systems; measuring the benefits of health care mainly using stated preferences techniques; and National Health Accounts.
- Professor William (Bill) Padula
William V. Padula, PhD is Assistant Professor of Pharmaceutical and Health Economics in the School of Pharmacy at the University of Southern California. His healthcare research explores the theoretical foundations of medical cost-effectiveness analysis, especially pertaining to issues around drug pricing and patient safety in hospitals.